Canada's Voice For
Biotechnology
Latest Company News
Biotechnology Industry News
- Cardiome Reports 2009 Results (Mar 9)
- DEKALB® Makes Additional Supplies of Top-Selling Canola Hybrid Available (Mar 9)
- Oncolytics Biotech(R) Inc. Announces 2009 Year End (Mar 9)
- $300,000 Canadian Institutes of Health Research grant awarded to Medicago, McGill University and the Research Institute of the McGill University Health Centre (Mar 8)
- OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2009 and Provides Outlook for 2010 (Mar 8)
- Allon Adopts Shareholder Rights Plan (Mar 8)
- YM BioSciences increases offering size to approximately US$17.5 million (Mar 8)
- Angiochem to Present at Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10 (Mar 8)
- BioMS Medical Reports Spectral Investment (Mar 4)
- 2010 BIO International Convention Expected to Bring More Than $25 Million to Chicago (Mar 4)
- IntelGenx and Cannasat Announce Letter of Intent for Relivar License (Mar 4)
- Transition to Acquire Exclusive Rights to Preclinical Diabetes Assets (Mar 3)
- BioMS Medical reports Spectral receives FDA approval to initiate pivotal trial and closes financing for $19.5 million (Mar 3)
- SemBioSys completes private placement (Mar 3)
- Monsanto Implements New Policy in Support of Insect Resistance Management Requirements (Mar 2)
- YM sees nimotuzumab license unaffected by civil claim against licensor (Mar 2)
- Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine (Mar 2)
- Theratechnologies Announces Publication of
Second Phase 3 Results in JAIDS (Mar 1)
-
$300,000 Canadian Institutes
of Health Research grant awarded to Medicago, McGill University and the Research
Institute of the McGill University Health Centre (Mar 1)
- enGene Inc. to Present Research Data on EG-10 for Inflammatory Bowel Disease (IBD) (Feb 25)
- Stem Cell Therapeutics Corp. Announces Presentations at the American Stroke Association's International Stroke Conference 2010 (Feb 25)
- Resverlogix Activates First Site for ASSURE 1 Clinical Trial (Feb 25)
- CO2 Solution Stock Option Grant (Feb 25)
- Protox revises terms of private placement (Feb 25)
- Theratechnologies announces a tentative new date for the FDA Advisory Committee review of the tesamorelin New Drug Application (Feb 25)
- Kane Biotech's Antibiofilm Technologies Published in Two New Scientific Books (Feb 23)
- Allon Presents Peripheral Neuropathy Preclinical Efficacy Data For AL-309 (Feb 23)
- Immunovaccine Appoints James Hall as new Board Member (Feb 23)
- Ontario Oil and Protein Seed Crops Committee Data Sends Clear Message-GenuityTM Roundup Ready 2 YieldTM Technology Provides Major Yield Advantage (Feb 23)
- Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement (Feb 22)
- LAB Research names new chief financial officer and expands senior scientific team in Hungary (Feb 22)
- Gowlings
Places in Top Tier of World IP Survey for 14th Consecutive Year (Feb 21)
- CO2 Solution Featured in New York
Times
Article highlights Company's technology for low-cost carbon dioxide
capture (Feb 18)
- Medicago invited to present at the 6th WHO's
meeting on evaluation of pandemic influenza prototype vaccines in clinical
trials (Feb 17)
- Dr. Alan Shaw Joins CO2 Solution's Board of Directors (Feb 17)
- Angiotech Pharmaceuticals and partner Athersys
announces completion of patient enrollment in phase I study of Multistem(R) in
acute myocardial infarction (Feb 17)
- Pfizer Canada Cardiovascular Research Awards
Program Currently Accepting Entries (Feb 17)
- Cardiome Pharma Corp. Announces US$25 Million Advance on Line of Credit
(Feb 16)
- Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights- Payment to Bioniche of US$8M by Endo Pharmaceuticals - (Feb 16)
- Abbott Completes Acquisition of Solvay Pharmaceuticals (Feb 16)
- Stem Cell Therapeutics Corp. Provides Update on Modified REGENESIS Phase IIb Stroke Trial (Feb 16)
- Thallion Pharmaceuticals and LFB Biotechnologies Sign Definitive Agreement to Develop and Commercialize Treatment for E. Coli (STEC) Infection (Feb 16)
- Dr. Albert Friesen Appointed to the Board of Directors of the Canada Foundation for Innovation (Feb 16)
- Lignol and Novozymes to Collaborate on Biofuel
from Wood (Feb 16)
- Oncolytics Biotech(R) Inc. Receives Approval
from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck
Cancers (Feb 16)
- Microbix Completes $1,300,000 Private
Placement (Feb 16)
- Microbix Cash-Flow Position Improves Markedly
in 1st Quarter; Expects Strong 2nd Quarter & Second Half 2010 (Feb 16)
- ProMetic Closes USD 13 Million Loan and Equity Financing (Feb 11)
- Novo Nordisk files annual report with the SEC (Feb 11)
- YM BioSciences presents CYT387 and CYT997 data at international cancer conference (Feb 11)
- DEKALB®'s New 73 Series of Canola Hybrids Recommended for Registration (Feb 11)
-
- Biovail Enters into License and Collaboration
Agreement with Alexza for AZ-004 (Feb 10)
- Bioniche Reports Fiscal 2010 Second Quarter
Results (Feb 10)
- YM BioSciences granted two US patents for
AeroLEF(R) (Feb 10)
- Health Canada approves CERVARIX(TM), new GSK cervical cancer vaccine (Feb 9)
- YM BioSciences reports second quarter 2010 operational and financial results (Feb 8)
- mmunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate (Feb 8)
- Amorfix announces third quarter 2010
results (Feb 8)
- Resverlogix Completes Patient Recruitment
for ASSERT Trial
Full enrollment occurs five months ahead of
schedule (Feb 8)
- Medicago named to TSX Venture 50 (Feb 5)
- Haemacure Obtains Extension of Time to File Proposal to Creditors, Haemacure
Shares to be Delisted from the Toronto Stock Exchange (Feb 5)
- Cannasat Announces Signing of Letter of Intent for In-Licensing of Parkinson's Disease Technology (Feb 4)
- Afexa Life Sciences Inc., Maker of COLD-FX®, Appoints Michael D. Obert as Chief Legal Officer and Senior Vice President Corporate Development (Feb 4)
- Immunovaccine Provides Corporate Update (Feb 4)
- DNP Green Technology Acquires Sinoven Biopolymers (Feb 4)
- Angiotech Pharmaceuticals Announces Conference Call and Webcast
Fourth Quarter and Year End 2009 Financial Results (Feb 4)
- Merck Partners with BC Centre for Excellence in HIV/AIDS for Seek and Treat research program to reduce HIV/AIDS incidence in BC (Feb 4)
- ProMetic Life Sciences Inc./VCJD Infection: A Continuing Threat to Public Health(Feb 4)
- BIO Welcomes Obama Proposal to Achieve Advanced Biofuels Targets, Final Rules
on Renewable Fuel Standard (Feb 3)
- Chemaphor Announces Positive Results of Pilot Canine Clinical Trial of an OximunolTM Supplement (Feb 2)
- LAB Research announces important changes to its Senior management team in Canada (Feb 2)
- $5 MILLION FOR GROUNDBREAKING BIOPHARMACEUTICAL RESEARCH (Feb 2)
- Novozymes and ProMetic Enter Into Alliance for Purification of Albumin-Fusion Proteins (Feb 2)
- Novo Nordisk Announces final results (Feb 2)
- MEDEC Launches New and Improved Website (Feb 2)
- Cannasat Update From Anthony Giovinazzo, President & CEO (Feb 1)
- Arthur J. Higgins, CEO of Bayer HealthCare,
Appointed to Resverlogix Board of Directors (Feb 1)
- YM BioSciences completes merger with
Cytopia (Feb 1)
- SemBioSys' plant-made Biosimilar Insulin featured on CTV News, Canada
AM
(Feb 1)
